zinc supplementation in ulcerative colitis

Phase 3

Recruiting

• Conditions: lcerative Colitis.; Ulcerative colitis, unspecified; K51.9

• Registration Number: IRCT20190710044172N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Body mass index 18.5 to 35
Diagnosis of ulcerative colitis according to the patient's symptoms, tests and colonoscopy image and intestinal sample pathology
Mild to moderate active form of the disease according to the Mayo questionnaire
No change in clinical symptoms during the last week of entering the study
Absence of concomitant diseases such as malignant diseases and other inflammatory diseases (cancer, kidney failure, heart failure, liver disorders, Wilson's, rheumatoid arthritis, diabetes, psoriasis, Behcet and other inflammatory and autoimmune diseases)
No hospitalization and no medication changes during the last 3 months due to the severity of the disease
Not having an acute disease (cold, corona and any other viral-bacterial-fungal disease)
No intestinal surgery
Not taking zinc supplements in the last 2 months
Not taking supplements containing antioxidants - omega 3 - vitamin D - probiotic - vitamin E - vitamin A - multivitamin in the last two months

Exclusion Criteria

Use of infliximab, Adalimumab, high dose of corticosteroids (above 40 mg), NSAIDs
pregnant and lactating women
Taking contraceptives
Implementation of special diet such as vegetarian diet, ketogenic diet and gluten-free diet

Study & Design

• Study Type: interventional
• Study Design: Not specified